Asthma Drug's hidden effects revealed in small study
NCT ID NCT05063981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how mepolizumab, a biologic drug, changes inflammation in people with severe eosinophilic asthma. Researchers measured immune and metabolic markers in the nose, lungs, and blood of 15 adults. The goal was to better understand the drug's full impact beyond just reducing asthma attacks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituti Clinici Scientifici Maugeri IRCCS
Telese Terme, BN, 82037, Italy
-
Istituti Clinici Scientifici Maugeri IRCCS
Tradate, Varese, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an asthma drug shrink nasal polyps? a major trial seeks answers
- Can a single drug shrink nasal polyps and restore breathing?
- AI and a smartphone app may let kids with asthma skip clinic visits
- Nanoparticle steroid spray could transform recovery after sinus surgery
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Short steroid course after first wheeze may stop asthma before it starts